Literature DB >> 30166482

CRISPR-Cas guides the future of genetic engineering.

Gavin J Knott1, Jennifer A Doudna2,3,4,5,6.   

Abstract

The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Copyright © 2018, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30166482      PMCID: PMC6455913          DOI: 10.1126/science.aat5011

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  66 in total

1.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 2.  Repair of strand breaks by homologous recombination.

Authors:  Maria Jasin; Rodney Rothstein
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

3.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

4.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

6.  Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors:  Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

7.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

8.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

Authors:  F J M Mojica; C Díez-Villaseñor; J García-Martínez; C Almendros
Journal:  Microbiology       Date:  2009-03       Impact factor: 2.777

9.  Self versus non-self discrimination during CRISPR RNA-directed immunity.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Nature       Date:  2010-01-13       Impact factor: 49.962

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more
  293 in total

1.  Very fast CRISPR on demand.

Authors:  Yang Liu; Roger S Zou; Shuaixin He; Yuta Nihongaki; Xiaoguang Li; Shiva Razavi; Bin Wu; Taekjip Ha
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

2.  Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Authors:  Rafet Basar; May Daher; Nadima Uprety; Elif Gokdemir; Abdullah Alsuliman; Emily Ensley; Gonca Ozcan; Mayela Mendt; Mayra Hernandez Sanabria; Lucila Nassif Kerbauy; Ana Karen Nunez Cortes; Li Li; Pinaki P Banerjee; Luis Muniz-Feliciano; Sunil Acharya; Natalie W Fowlkes; Junjun Lu; Sufang Li; Stephan Mielke; Mecit Kaplan; Vandana Nandivada; Mustafa Bdaiwi; Alexander D Kontoyiannis; Ye Li; Enli Liu; Sonny Ang; David Marin; Lorenzo Brunetti; Michael C Gundry; Rolf Turk; Mollie S Schubert; Garrett R Rettig; Matthew S McNeill; Gavin Kurgan; Mark A Behlke; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2020-07-28

3.  Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.

Authors:  Max J Gramelspacher; Zhonggang Hou; Yan Zhang
Journal:  Methods       Date:  2019-06-20       Impact factor: 3.608

Review 4.  Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage.

Authors:  Zhicheng Zuo; Jin Liu
Journal:  Curr Opin Struct Biol       Date:  2020-02-18       Impact factor: 6.809

Review 5.  Blood disease-causing and -suppressing transcriptional enhancers: general principles and GATA2 mechanisms.

Authors:  Emery H Bresnick; Kirby D Johnson
Journal:  Blood Adv       Date:  2019-07-09

Review 6.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

7.  Machine learning predicts new anti-CRISPR proteins.

Authors:  Simon Eitzinger; Amina Asif; Kyle E Watters; Anthony T Iavarone; Gavin J Knott; Jennifer A Doudna; Fayyaz Ul Amir Afsar Minhas
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

Review 8.  Recent advances in the microbial production of isopentanol (3-Methyl-1-butanol).

Authors:  Weerawat Runguphan; Kittapong Sae-Tang; Sutipa Tanapongpipat
Journal:  World J Microbiol Biotechnol       Date:  2021-05-27       Impact factor: 3.312

9.  Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice.

Authors:  Kai Miao; Xin Zhang; Sek Man Su; Jianming Zeng; Zebin Huang; Un In Chan; Xiaoling Xu; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2018-11-28       Impact factor: 5.157

10.  PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage.

Authors:  Tautvydas Karvelis; Greta Bigelyte; Joshua K Young; Zhenglin Hou; Rimante Zedaveinyte; Karolina Budre; Sushmitha Paulraj; Vesna Djukanovic; Stephen Gasior; Arunas Silanskas; Česlovas Venclovas; Virginijus Siksnys
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.